Skip to content

Clinical trials

Phase 3 Crohn Disease trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Crohn Disease Phase: Phase 3 Country / region: Czechia Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20063
20071
20082
20091
20102
20115
20131
20141
20154
20165
20179
20188
20193
20202
20222
20233
20243
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Terminated12
Recruiting11
Active, not recruiting7
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie10
Takeda8
Celgene6
Janssen Research & Development, LLC5
GlaxoSmithKline4
Eli Lilly and Company3
Janssen-Cilag Ltd.3
Abbott2
Hoffmann-La Roche2
Lakefront Biotherapeutics NV2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Crohn Disease64
Inflammatory Bowel Diseases6
Colitis, Ulcerative5
Colitis2
Fistula1
Gastroenteritis1
Intestinal Fistula1
Irritable Bowel Syndrome1
Obesity1
Overweight1

Trials

Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.